Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Cancer Medicine|May 6, 2020
PD-L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B-cell lymphoma treated with rituximab-based multi-agent chemotherapyYuka Suzuki, Kei Kohno, Kosei Matsue, et al.
Pathology International|January 29, 2019
Divergence and heterogeneity of neoplastic PD-L1 expression: Two autopsy case reports of intravascular large B-cell lymphomaAyako Sakakibara, Yuichiro Inagaki, Eiki Imaoka, et al.
International Journal of Hematology|May 23, 2008
Evaluation of organ involvement in intravascular large B-cell lymphoma by 18F-fluorodeoxyglucose positron emission tomographyKazuyuki Shimada, Hiroshi Kosugi, Satoko Shimada, et al.
Human Pathology|September 10, 2013
Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case reportSeiichi Kato, Tomoko Miyata, Katsuyoshi Takata, et al.
Oncogene|May 17, 2021
Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphomaShunsuke Kunou, Kazuyuki Shimada, Mika Takai, et al.
Breast Cancer (Tokyo, Japan)|April 14, 2019
Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriersSatoko Shimada, Reiko Yoshida, Eri Nakashima, et al.
Frontiers in Immunology|March 14, 2025
Increased sputum peripheral helper T cells are associated with the severity of rheumatoid arthritis but not with the severity of airway diseaseEito Yokoi, Keiko Wakahara, Saya Nakamura, et al.
Oncotarget|January 6, 2017
Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolismTomohiro Aoki, Kazuyuki Shimada, Akihiko Sakamoto, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|September 13, 2021
Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief reviewAyako Sakakibara, Kei Kohno, Eri Ishikawa, et al.
Histopathology|January 31, 2018
Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cellsAyako Sakakibara, Kei Kohno, Ahmed E Eladl, et al.
Pageof 5